| Trial Identifier: | 217043 |
| Sponsor: | GlaxoSmithKline |
| Start Date: | November 2021 |
| Primary Completion Date: | March 2025 |
| Study Completion Date: | March 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| DOMINICAN_REPUBLIC | Santo Domingo Este, DOMINICAN_REPUBLIC, N/A |
| FINLAND | Espoo, FINLAND, 02230 |
| FINLAND | Helsinki, FINLAND, 00100 |
| FINLAND | Jarvenpaa, FINLAND, 04400 |
| FINLAND | Kokkola, FINLAND, 67100 |
| FINLAND | Oulu, FINLAND, 90220 |
| FINLAND | Seinajoki, FINLAND, 60100 |
| GERMANY | Gilching, GERMANY, 82205 |
| GERMANY | Schoenau am Koenigssee, GERMANY, 83471 |
| HONDURAS | San Pedro Sula, HONDURAS, 21101 |
| POLAND | Bydgoszcz, POLAND, 85-048 |
| POLAND | Krakow, POLAND, 30-644 |
| POLAND | Krakow, POLAND, 30-348 |
| POLAND | Lubon, POLAND, 62-030 |
| POLAND | Siemianowice Slaskie, POLAND, 41-103 |
| POLAND | Torun, POLAND, 87-100 |
| POLAND | Trzebnica, POLAND, 55-100 |
| POLAND | Warszawa, POLAND, 02-647 |
| POLAND | Wroclaw, POLAND, 50368 |
| SOUTH_AFRICA | Parow Valley, SOUTH_AFRICA, 7505 |
| SOUTH_AFRICA | Soweto Gauteng, SOUTH_AFRICA, 2013 |
| SPAIN | ALMERIA, SPAIN, 04120 |
| SPAIN | Burgos, SPAIN, 09006 |
| SPAIN | Madrid, SPAIN, 28041 |
| SPAIN | Madrid, SPAIN, 28040 |
| SPAIN | Madrid, SPAIN, 28046 |
| SPAIN | MADRID, SPAIN, 28222 |
| SPAIN | MALAGA, SPAIN, 29004 |
| SPAIN | Marbella, SPAIN, 29600 |
| SPAIN | Santiago de Compostela, SPAIN, 15706 |
| UNITED_KINGDOM | Exeter, UNITED_KINGDOM, EX2 5DW |
| UNITED_KINGDOM | Oxford, UNITED_KINGDOM, OX3 7LE |